Dermatology

Medicare, coding and reimbursement challenges that lie aheadSpeaking at the American Academy of Dermatology annual meeting in February, Dr. Brett Coldiron described challenges dermatologists should be prepared for this year, including Medicare payment reductions, insurers' cost-saving strategies and practice consolidations.
Transgender dermatology care faces unique challengesThe transgender dermatology patient may face a unique set of challenges doctors should be prepared to address, says Dr. Brian Ginsberg.
Up-and-coming fillers and neuromodulatorsInjectable aesthetic products recently FDA-approved or in late stages of development include polycaprolactone, a new hyaluronic acid and multiple neuromodulators.
Biologics offer promise for hidradenitis suppurativa treatmentWith one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.
Managing hedgehog therapies for basal cell carcinomaWhile the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.
The promise of biologic therapy in dermatologyDuring the American Academy of Dermatology’s annual meeting, physicians addressed the monumental changes that have occurred since the advent of biologic therapy for systemic autoimmune conditions, such as psoriasis and atopic dermatitis. Today, some patients are able to achieve complete disease clearance. Although there may be viable treatments for these conditions, access to care and medication adherence remain top issues, physicians say.
Atopic dermatitis: From guidelines to practiceThis week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.
Spironolactone for hormonal acneFemale patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.
Vitamin D overload concerns expressed at AADThere's been much debate in the literature about the need for and role of vitamin D, which may encourage patients to overdo vitamin dosing, researchers said at AAD 2018 this week.
Multidisciplinary care improves patient outcomesMultidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.